Home › Funds › Octagon Capital Advisors LP › IRON
Octagon Capital Advisors LP position in IRON
DISC MEDICINE INC · Health Care
Octagon Capital Advisors LP reported holding 270,000 shares of IRON (DISC MEDICINE INC) in its Q3 2026 13F filing — a position valued at US$17.7M, representing 2.35% of its reported portfolio and ranking #9 among its reported holdings. Octagon Capital Advisors LP has disclosed IRON holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Octagon Capital Advisors LP's IRON position evolved
Octagon Capital Advisors LP first disclosed a stake in IRON in Q1 2026 at 270,000 shares (US$17.3M). The position peaked in Q2 2026 at 270,000 shares, worth US$19.7M. Across 3 filings, Octagon Capital Advisors LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 270,000 shares valued at US$17.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 270.00K | $17.26M | New |
| Q2 2026 | 270.00K | $19.75M | Hold |
| Q3 2026 | 270.00K | $17.67M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRON and 13F data
IRON (DISC MEDICINE INC) is a Health Care company. 34 other funds we track also report a position in IRON — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$107.0M), Atlas Venture Life Science Advisors, LLC (US$90.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRON
- RA CAPITAL MANAGEMENT, L.P. 2.45M sh · $160.39M · Q3 2026
- Vestal Point Capital, LP 1.64M sh · $107.03M · Q3 2026
- Atlas Venture Life Science Advisors, LLC 1.38M sh · $90.60M · Q3 2026
- TCG Crossover Management, LLC 1.34M sh · $87.84M · Q3 2026
- Logos Global Management LP 1.01M sh · $66.44M · Q3 2026
- Opaleye Management Inc. 855.00K sh · $62.53M · Q2 2026
- Frazier Life Sciences Management, L.P. 934.85K sh · $61.20M · Q3 2026
- Siren, L.L.C. 888.40K sh · $58.15M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 657.00K sh · $43.01M · Q3 2026
- Saturn V Capital Management LP 612.66K sh · $40.10M · Q3 2026
- Bellevue Group AG 560.00K sh · $36.66M · Q3 2026
- ARMISTICE CAPITAL, LLC 500.00K sh · $32.73M · Q3 2026
More on Octagon Capital Advisors LP
FAQ
How long has Octagon Capital Advisors LP held IRON?
Octagon Capital Advisors LP has disclosed IRON holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Octagon Capital Advisors LP's current position in IRON?
As of Q3 2026, Octagon Capital Advisors LP holds 270.00K shares of IRON (DISC MEDICINE INC), valued at $17.67M, representing 2.35% of its reported portfolio and ranking #9.
Has Octagon Capital Advisors LP been buying or selling IRON?
In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP held unchanged its position in IRON. The position peaked in Q2 2026 at 270.00K shares.
Which other funds hold IRON?
Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Atlas Venture Life Science Advisors, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.